English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
GEN 与 Sulfateq BV 公布治疗阿尔茨海默病及其他神经退行性疾病的候选药物 SUL-238 的第一阶段临床试验积极结果
Jul 29, 2025 08:00 HKT
GEN 與 Sulfateq BV 公佈治療阿茲海默症及其他神經退化性疾病的候選藥物 SUL-238 的第一階段臨床試驗正面結果
Jul 29, 2025 08:00 HKT
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
Jul 29, 2025 04:00 HKT
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
Jul 28, 2025 20:00 HKT
維立志博於聯交所主板成功上市
Jul 25, 2025 19:36 HKT
维立志博于联交所主板成功上市
Jul 25, 2025 18:00 HKT
亿胜生物多剂量地夸磷索钠滴眼液获中国国家药品监督管理局批准上市
Jul 25, 2025 10:52 HKT
億勝生物多劑量地誇磷索鈉滴眼液獲中國國家藥品監督管理局批准上市
Jul 25, 2025 10:52 HKT
Multi-Dose Diquafosol Sodium Eye Drops Obtained Approval from NMPA for Commercialisation in China
Jul 25, 2025 10:52 HKT
云顶新耀宣布配售股份 拟集资约15.725亿港元
Jul 25, 2025 10:01 HKT
雲頂新耀宣布配售股份 擬集資約15.725億港元
Jul 25, 2025 10:01 HKT
Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million
Jul 25, 2025 10:01 HKT
镁信健康携手多方力量 共促粤港澳大湾区医疗保险发展
Jul 25, 2025 09:55 HKT
鎂信健康攜手多方力量 共促粵港澳大灣區醫療保險發展
Jul 25, 2025 09:55 HKT
HKTDC Research Report: Exploring Opportunities in Hong Kong's Proprietary Chinese Medicine Industry
Jul 24, 2025 17:43 HKT
아반토코리아, 수원 사무실 광교중앙역 인근으로 이전
Jul 24, 2025 09:00 HKT
Avantor Relocates Korea Office in Suwon to Support Growth and Enhance Collaboration
Jul 24, 2025 09:00 HKT
冠科生物圣地亚哥实验室获 CLIA 认证 增强临床试验支持能力
Jul 23, 2025 09:00 HKT
冠科生物聖地牙哥實驗室獲 CLIA 認證 增強臨床試驗支援能力
Jul 23, 2025 09:00 HKT
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets
Jul 22, 2025 13:00 HKT
Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: